Hanover Insurance
THG
$223.11
+1.92%
The Hanover Insurance Group, Inc. is a holding company that provides property and casualty insurance products and services through independent agents and brokers across the United States, operating through Core Commercial, Specialty, Personal Lines, and Other segments. As a regional P&C insurer, it differentiates itself through its exclusive reliance on independent distribution and a diversified portfolio spanning commercial and personal lines. The current investor narrative centers on the company's robust premium growth and margin expansion, evidenced by a 6.6% YoY revenue increase in Q1 2026 and a strong underwriting performance, while also navigating the broader industry's pricing and catastrophe risk environment.…
THG
Hanover Insurance
$223.11
Related headlines
Investment Opinion: Should I buy THG Today?
Based on the analysis, THG is rated a Buy. The company's strong revenue growth, improving profitability, and attractive valuation relative to peers provide a compelling risk/reward. The consensus rating is 'Hold' with an average target price of $235.88, implying a 4.7% upside from the current price of $225.29. However, the low PE and high ROE suggest the market is undervaluing the company's earnings power.
Supporting evidence includes: trailing PE of 9.87x vs. industry average of 15x, a 34% discount; revenue growth of 6.6% YoY in Q1 2026; net margin of 10.0% and ROE of 18.5%; and free cash flow of $1.25B. The PEG ratio of 0.18 indicates the stock is undervalued relative to its growth rate. The stock's 1-year return of 31.3% outperforms the S&P 500, and the low beta of 0.28 provides downside protection.
Key risks include potential earnings deceleration, catastrophe losses, and competitive pressures. If the forward PE expands to the industry average of 15x, the stock could rise to $343, but this is unlikely in the near term. The rating would upgrade to Strong Buy if revenue growth accelerates above 10% or if the PE compresses below 8x. Conversely, a downgrade to Hold would occur if revenue growth falls below 3% or if the stock reaches the high target of $260. Overall, THG is undervalued relative to its history and peers, offering a favorable entry point for investors.
Sign up to view all
THG 12-Month Price Forecast
The AI assessment is bullish on THG, driven by its strong fundamentals and attractive valuation. The company's consistent revenue growth and high profitability metrics suggest it is undervalued relative to peers. The low beta and solid balance sheet provide downside protection. However, the medium confidence reflects the mixed analyst sentiment and potential for earnings deceleration. If THG can maintain its growth trajectory and the market re-rates it to a higher multiple, the stock could see significant upside. Key developments to watch include quarterly earnings, catastrophe losses, and industry pricing trends. An upgrade to high confidence would occur if revenue growth accelerates above 8% and the stock breaks above $240, while a downgrade would be triggered by a major catastrophe or a decline in net margin below 8%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Hanover Insurance's 12-month outlook, with a consensus price target around $236.50 and implied upside of +6.0% versus the current price.
Average Target
$236.50
0 analysts
Implied Upside
+6.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$222 - $260
Analyst target range
The target price range spans from $222.00 to $260.00, with a spread of $38.00, which is relatively wide and signals moderate uncertainty about the company's future performance. The high target of $260.00 likely assumes continued strong underwriting results, favorable reserve development, and potential multiple expansion, while the low target of $222.00 may factor in potential catastrophe losses or competitive pressures. Recent institutional ratings show a mix of actions, with some firms like Keefe, Bruyette & Woods downgrading from Outperform to Market Perform in July 2026, while others like Piper Sandler and Oppenheimer maintain Overweight/Outperform ratings, indicating a divergence in views. The wide spread and mixed ratings suggest that investors should monitor quarterly earnings and industry trends closely.
Bulls vs Bears: THG Investment Factors
THG presents a compelling bull case with strong revenue growth, robust earnings, and a discounted valuation relative to peers. The stock's momentum and high ROE indicate operational excellence. However, the bear case highlights the stock's proximity to 52-week highs, mixed analyst sentiment, and potential earnings deceleration implied by the forward PE. Currently, the bull case has stronger evidence, given the fundamental strength and valuation discount. The key tension is whether the market will re-rate THG to a higher multiple, driven by sustained underwriting performance, or if earnings will normalize, capping upside. This hinges on the company's ability to maintain premium growth and manage catastrophe risks.
Bullish
- Strong Revenue Growth Acceleration: Q1 2026 revenue grew 6.6% YoY to $1.70B, up from 2.9% growth in Q1 2025, marking the fourth consecutive quarter of YoY growth. This acceleration is driven by strong premium retention and new business across all segments, particularly Core Commercial and Personal Lines.
- Impressive Net Income Growth: Q1 2026 net income surged 45.7% YoY to $186.8M, reflecting improved underwriting and higher investment income. This drove EPS of $5.26, up from $3.50 in the prior year quarter, showcasing strong operational leverage.
- Attractive Valuation with High ROE: THG trades at a trailing PE of 9.87x, a 34% discount to the industry average of 15x, while delivering an ROE of 18.5% and net margin of 10.0%. This combination of low valuation and high profitability is rare and suggests potential for multiple expansion.
- Strong Price Momentum and Relative Strength: The stock is up 31.3% over the past year, outperforming the S&P 500's 20.4% gain, with relative strength of 10.9x over the same period. The 6-month change of 31.1% confirms the strong uptrend, indicating investor confidence.
Bearish
- Potential Overextension Near Highs: The stock trades at 95.4% of its 52-week range, near the high of $236.07. This leaves limited upside in the near term and increases the risk of a pullback, especially if market sentiment shifts.
- Mixed Analyst Sentiment: The consensus rating is 'Hold' with a mean score of 2.625, and the target price spread is wide ($222-$260). Recent downgrades by Keefe, Bruyette & Woods from Outperform to Market Perform contrast with Overweight ratings from Piper Sandler, indicating uncertainty.
- Forward PE Higher Than Trailing: The forward PE of 11.57x is higher than the trailing PE of 9.87x, suggesting the market expects earnings to decline or grow slowly. This could be due to potential catastrophe losses or competitive pressures.
- Catastrophe Risk Exposure: As a P&C insurer, THG is exposed to catastrophe losses, which can cause significant earnings volatility. The low beta of 0.28 provides some stability, but a major event could still hit results.
THG Technical Analysis
THG has been in a sustained uptrend over the past year, with the stock price rising 31.3% over the last 12 months, significantly outperforming the S&P 500's 20.4% gain. The current price of $225.29 sits at 95.4% of its 52-week range (between $165.50 low and $236.07 high), indicating the stock is trading near its highs, reflecting strong momentum and investor confidence, though it also suggests the potential for overextension. The 6-month price change of 31.1% confirms the strength of the longer-term trend, with the stock consistently making higher highs and higher lows.
Beta
0.28
0.28x market volatility
Max Drawdown
-10.0%
Largest decline past year
52-Week Range
$167-$236
Price range past year
Annual Return
+28.3%
Cumulative gain past year
| Period | THG Return | S&P 500 |
|---|---|---|
| 1m | +3.7% | +1.9% |
| 3m | +14.3% | +2.3% |
| 6m | +26.8% | +10.6% |
| 1y | +28.3% | +19.5% |
| ytd | +24.6% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
THG Fundamental Analysis
Revenue has been growing steadily, with Q1 2026 revenue of $1.70 billion, up 6.6% YoY from $1.60 billion in Q1 2025. This marks the fourth consecutive quarter of YoY growth, with Q4 2025 revenue of $1.67 billion, Q3 2025 revenue of $1.66 billion, and Q2 2025 revenue of $1.65 billion, showing a clear acceleration from the 2.9% growth in Q1 2025. The growth is driven by strong premium retention and new business across all segments, particularly in Core Commercial (revenue of $623.5 million) and Personal Lines ($685.7 million), which together account for over 77% of total segment revenue. The company's net income has also improved significantly, with Q1 2026 net income of $186.8 million, up 45.7% from $128.2 million in the prior year quarter, reflecting improved underwriting and higher investment income.
Quarterly Revenue
$1.7B
2026-03
Revenue YoY Growth
+6.6%
YoY Comparison
Gross Margin
43.7%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is THG Overvalued?
Given that THG has positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 9.87x, while the forward PE is 11.57x, indicating that the market expects earnings to grow modestly, as the forward multiple is higher. The gap between trailing and forward PE suggests that while current earnings are strong, the market is pricing in a slight deceleration or normalization in earnings growth. Compared to the industry average PE of 15x (based on typical P&C insurers), THG trades at a 34% discount, which is notable given its superior profitability metrics, such as a net margin of 10.0% and ROE of 18.5%.
PE
9.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 7x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include moderate leverage with a debt-to-equity ratio of 0.34, which is manageable but could strain if investment losses occur. The company's net margin of 10.0% is solid, but it is sensitive to underwriting cycles; a downturn could compress margins. Revenue concentration in Personal Lines (over 40% of segment revenue) exposes THG to competitive pricing pressures and regulatory changes. Free cash flow of $1.25B provides a cushion, but a significant catastrophe could erode capital and force dividend cuts or capital raises.
Market risks include valuation compression if the stock's premium to historical averages unwinds; the trailing PE of 9.87x is below the industry average, but the forward PE suggests expectations of slower growth. The stock's low beta of 0.28 reduces macro sensitivity, but it also means less upside in a bull market. Competitive threats from larger insurers with scale advantages could pressure pricing. Regulatory changes in insurance markets, such as rate caps or stricter solvency requirements, could impact profitability. The wide analyst target spread ($222-$260) signals uncertainty, and recent downgrades highlight potential headwinds.
In a worst-case scenario, a combination of catastrophic losses, a prolonged soft pricing cycle, and investment portfolio losses could severely impact earnings. The 52-week low of $165.50 represents a potential downside of -26.5% from the current price of $225.29. Historical max drawdown of -10.02% suggests that while the stock is less volatile, a severe event could still cause significant losses. If the company were to cut its dividend or issue equity to shore up capital, the stock could fall further, potentially to the low target of $222 or below, though the bear case target is $222, implying a -1.5% downside.
FAQ
The key risks include: 1) Catastrophe losses, which can cause significant earnings volatility; 2) Competitive pressures in the P&C market, particularly in Personal Lines, which could compress margins; 3) Valuation risk, as the stock trades near 52-week highs and could pull back; 4) Regulatory changes that could limit rate increases or impose stricter capital requirements. The low beta of 0.28 reduces macro sensitivity, but these company-specific risks remain. The most severe risk is a major catastrophe, which could lead to a -26.5% decline to the 52-week low of $165.50.
The 12-month forecast for THG is moderately bullish. In the base case (50% probability), the stock is expected to trade around the average analyst target of $235.88, implying a 4.7% upside. In the bull case (30% probability), the stock could reach $260, driven by strong earnings and multiple expansion. In the bear case (20% probability), the stock could fall to $222 or lower, due to catastrophe losses or a downturn in the cycle. The most likely scenario is the base case, assuming stable underwriting performance and no major catastrophes. The stock's low beta and strong fundamentals provide a favorable risk/reward profile.
THG is undervalued relative to its peers and its own growth prospects. The trailing PE of 9.87x is significantly below the industry average of 15x, and the PEG ratio of 0.18 indicates that the stock is cheap relative to its earnings growth. The forward PE of 11.57x is higher than the trailing, suggesting the market expects earnings to normalize, but this still leaves room for upside if the company beats expectations. The stock's price-to-book ratio of 1.83x is reasonable for an ROE of 18.5%. Overall, the market is pricing in a conservative outlook, providing a margin of safety for investors.
THG is a good buy for investors seeking a value-oriented insurance stock with strong fundamentals. The stock trades at a trailing PE of 9.87x, a 34% discount to the industry average of 15x, while delivering an ROE of 18.5% and net margin of 10.0%. The average analyst target of $235.88 implies a 4.7% upside, but the low PEG ratio of 0.18 suggests the stock is undervalued relative to its growth. The main downside risk is a potential pullback from near 52-week highs, but the low beta of 0.28 provides stability. For long-term investors, THG offers a compelling risk/reward, especially if the market re-rates the stock to a higher multiple.
THG is more suitable for long-term investment due to its low beta (0.28), stable earnings, and dividend yield of 2.0%. The company's consistent revenue growth and high ROE suggest it can compound value over time. Short-term traders may find limited volatility, but the stock's proximity to 52-week highs could offer some momentum opportunities. For long-term investors, a minimum holding period of 3-5 years is recommended to capture the potential multiple expansion and dividend growth. The payout ratio of 19.7% leaves room for dividend increases, making it an attractive income stock for patient investors.